Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lupin Limited ( (IN:LUPIN) ) just unveiled an update.
Lupin Limited has announced the successful passing of resolutions via a postal ballot, including the re-appointment of Mr. Mark D. McDade as an Independent Director and a revision in the remuneration of Managing Director Mr. Nilesh D. Gupta. These resolutions, passed with the requisite majority, reflect the company’s ongoing governance and operational adjustments, potentially impacting its strategic direction and stakeholder relations.
More about Lupin Limited
Lupin Limited is a pharmaceutical company based in Mumbai, India, known for its focus on the development, production, and marketing of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients globally.
Average Trading Volume: 21,515
Technical Sentiment Signal: Buy
Current Market Cap: 909.5B INR
For a thorough assessment of LUPIN stock, go to TipRanks’ Stock Analysis page.